ab32529 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab32529 は 32 報の論文で使用されています。

  • Milewska M  et al. Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers. Ther Adv Med Oncol 10:1758834017746040 (2018). PubMed: 29383036
  • Li N  et al. Effects of isoliquiritigenin on ovarian cancer cells. Onco Targets Ther 11:1633-1642 (2018). PubMed: 29606882
  • Ruvolo PP  et al. Role of MSC-derived galectin 3 in the AML microenvironment. Biochim Biophys Acta 1865:959-969 (2018). PubMed: 29655803
  • Li L  et al. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway. Cell Biol Int N/A:N/A (2018). PubMed: 29762880
  • Nie X  et al. mTOR acts as a pivotal signaling hub for neural crest cells during craniofacial development. PLoS Genet 14:e1007491 (2018). PubMed: 29975682
  • Xu H  et al. SIL1 functions as an oncogene in glioma by AKT/mTOR signaling pathway. Onco Targets Ther 11:3775-3783 (2018). PubMed: 29997438
  • Chen W  et al. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/ß-catenin signaling pathways. Cancer Manag Res 10:1817-1826 (2018). PubMed: 29997441
  • Elster N  et al. Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer. Ther Adv Med Oncol 10:1758835918778297 (2018). PubMed: 30023006
  • Jiang Y  et al. TIPE2 governs macrophage polarization via negative regulation of mTORC1. Mol Med Rep 17:952-960 (2018). PubMed: 29115630
  • He J & Zhu J Collapsin Response Mediator Protein-2 Ameliorates Sevoflurane-Mediated Neurocyte Injury by Targeting PI3K-mTOR-S6K Pathway. Med Sci Monit 24:4982-4991 (2018). PubMed: 30018280
  • Liu W  et al. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism. Int J Oncol 50:1792-1800 (2017). PubMed: 28350132
  • Silva RAC  et al. Cardiac Remodeling Induced by All-Trans Retinoic Acid is Detrimental in Normal Rats. Cell Physiol Biochem 43:1449-1459 (2017). PubMed: 29017174
  • Cui N  et al. Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8(+) T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis. Chin Med J (Engl) 130:1211-1217 (2017). PubMed: 28485322
  • Wang C  et al. Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling. Oncotarget 8:100358-100370 (2017). PubMed: 29245984
  • Wang H  et al. IL-12 Influence mTOR to Modulate CD8+T Cells Differentiation through T-bet and Eomesodermin in Response to Invasive Pulmonary Aspergillosis. Int J Med Sci 14:977-983 (2017). PubMed: 28924369
  • Zhao J  et al. A disputed evidence on obesity: comparison of the effects of Rcan2(-/-) and Rps6kb1(-/-) mutations on growth and body weight in C57BL/6J mice. J Zhejiang Univ Sci B 17:657-71 (2016). WB ; Mouse . PubMed: 27604858
  • Gao B  et al. Eicosapentaenoic acid attenuates dexamethasome-induced apoptosis by inducing adaptive autophagy via GPR120 in murine bone marrow-derived mesenchymal stem cells. Cell Death Dis 7:e2235 (2016). WB ; Mouse . PubMed: 27228350
  • Zhang XY  et al. Endoplasmic reticulum chaperone GRP78 is involved in autophagy activation induced by ischemic preconditioning in neural cells. Mol Brain 8:20 (2015). PubMed: 25885223
  • Van Rechem C  et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov 5:255-63 (2015). Human . PubMed: 25564516
  • Zhang Y  et al. PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer. EBioMedicine 2:1944-56 (2015). PubMed: 26844273
  • Mei W  et al. Gambogenic acid kills lung cancer cells through aberrant autophagy. PLoS One 9:e83604 (2014). WB ; Human . PubMed: 24427275
  • Xu R  et al. The protease Omi regulates mitochondrial biogenesis through the GSK3ß/PGC-1a pathway. Cell Death Dis 5:e1373 (2014). WB ; Mouse . PubMed: 25118933
  • Xu LZ  et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells. Oncotarget 5:7498-511 (2014). WB ; Human . PubMed: 25115395
  • Mok KW  et al. rpS6 Regulates blood-testis barrier dynamics by affecting F-actin organization and protein recruitment. Endocrinology 153:5036-48 (2012). WB ; Rat . PubMed: 22948214
  • Sikora AG  et al. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res 16:1834-44 (2010). PubMed: 20215556
  • Ren B  et al. ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish. J Clin Invest 120:1217-28 (2010). PubMed: 20237411
  • Hennessy BT  et al. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics 6:129-51 (2010). Dot blot ; Human . PubMed: 21691416
  • Hennessy BT  et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116-24 (2009). PubMed: 19435916
  • Stemke-Hale K  et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68:6084-91 (2008). PubMed: 18676830
  • Maehama T  et al. RalA functions as an indispensable signal mediator for the nutrient-sensing system. J Biol Chem 283:35053-9 (2008). PubMed: 18948269
  • Kim WY  et al. A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy. Cancer Prev Res (Phila) 1:577-87 (2008). PubMed: 19139008
  • Ho CM  et al. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient. Clin Transplant 24:127-32 (0). PubMed: 19919613

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録